MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.
NCT07000292
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Lupus Nephritis (LN)
ANCA-Associated Glomerulonephritis
Interventions
DRUG:
Injection of MSC303
Sponsor
Shanghai Changzheng Hospital